Spark has priced its cure for a rare form of blindness at $425,000 per eye. But rather than the science or the cost, pharma is buzzing over the company’s outcomes-based pricing model
Amazon’s ability to attract other employers makes its healthcare coalition very formidable, experts say
As HCPs continue to be stretched for time to diagnose and interact with patients, health bots could help reduce HCP workload and drive patient engagement.